Latin America Protein Hydrolysis Enzymes Market

Latin America Protein Hydrolysis Enzyme Market Size

The Latin America Protein Hydrolysis Enzyme Market is projected to grow from USD 0.13 billion in 2025 to USD 0.14 billion in 2026 and reach USD 0.21 billion by 2034, registering a CAGR of 5.79% during the forecast period from 2026 to 2034.

A protein hydrolysis enzyme, commonly known as a protease or peptidase, is a biological catalyst that breaks down large, complex proteins into smaller peptide chains or individual amino acids. These biocatalysts are fundamental to optimizing processes across the food and beverage, animal feed,d and pharmaceutical sectors. The region operates as a global agricultural powerhouse,se providing a massive foundation for enzyme utilization. According to the Food and Agriculture Organization, Latin America and the Caribbean's annual cereal production has exceeded 290 million metric tons, while regional meat production continues to expand to meet 28% of the global beef supply. This colossal output necessitates advanced bioprocessing solutions to enhance yield and nutritional value. The Inter-American Development Bank indicates that increasing efficiency and market integration in Latin American agrifood sectors can unlock over $24 billion in untapped intraregional trade. The transition toward cleaner manufacturing processes and the rising consumer demand for easily digestible nutritional products further accelerate the adoption of these specialized enzymes. Regulatory bodies in major economies like Brazil and Mexico are increasingly approving novel enzymatic formulations to ensure food safety and improve industrial efficiency. This dynamic environment positions the region as a critical hub for biotechnological innovation in protein modification.

MARKET DRIVERS

Massive Growth in Meat Export Volumes Necessitates Advanced Protein Modification Techniques

The unprecedented expansion of the meat and poultry processing sector across the region accelerates the growth of the Latin American protein hydrolysis enzyme market. The region is a dominant global supplier of beef, pork,rk and poultry, requiring sophisticated enzymatic solutions to maximize yield and improve product texture. According to the Brazilian Association of Meat Exporting Industries (ABIEC), national beef exports reached a historic high of 3.50 million tonnes, while poultry exports tracked by the Brazilian Animal Protein Association (ABPA) exceeded 5.3 million tonnes. The Food and Agriculture Organization projects continuous global demand for animal protein sources, driving regional producers to adopt advanced processing mechanisms to optimize efficiency and maximize total carcass utilization. These biocatalysts effectively break down tough connective tissues, transforming low-value cuts into premium culinary products and generating high-protein hydrolysates for animal feed and human consumption. The relentless pressure to maintain competitive export volumes while adhering to strict international quality standards forces processors to integrate advanced enzymatic technologies. This continuous drive for operational efficiency and product enhancement guarantees a robust and expanding demand for specialized protein-cleaving enzymes throughout the regional meat industry.

Increasing Prevalence of Food Allergies Drives the Formulation of Specialized Nutritional Products

The escalating consumer awareness regarding food allergies and digestive sensitivities further boosts the expansion of the Latin America protein hydrolysis enzyme market. This propels the demand for these enzymes in the clinical nutrition and infant formula sectors. Extensively hydrolyzed proteins are essential for creating hypoallergenic formulas that prevent allergic reactions in sensitive infants and provide easily digestible nutrition for patients with compromised gastrointestinal systems. International pediatric allergy bodies show that cow's milk protein allergy affects 2% to 3% of infants globally, establishing a primary basis for hypoallergenic formulas. The Pan American Health Organization prioritizes the integration of specialized food fortification and nutritional therapeutics into public healthcare frameworks to eliminate persistent micronutrient deficiencies across Latin America. Protein hydrolysis enzymes precisely cleave large milk proteins into minimal peptides that the immune system no longer recognizes as threats. The expanding middle class in countries like Mexico and Argentina is willing to invest heavily in premium health and wellness products,s including sports nutrition and medical foods that rely on these advanced enzymatic processes. This profound shift toward personalized and easily assimilated nutritional solutions ensures sustained and accelerated growth for high-purity hydrolytic enzymes in the pharmaceutical and dietary supplement markets.

MARKET RESTRAINTS

Substantial Financial Barriers Associated with Bioprocessing and Purification Limit Widespread Adoption

The significant financial burden associated with the fermentation, extraction,n and purification of specialized protein hydrolysis enzymes is a major restraint to the Latin American market. Producing high-purity biocatalysts requires highly controlled bioprocessing environments, expensive nutrient media, and complex downstream purification technologies to ensure the final product is free from microbial contaminants. As per the Economic Commission for Latin America and the Caribbean, the high capital expenditure required to establishstate-of-the-artt enzyme production plants deters small and medium enterprises from entering the market. Furthermore, maintaining the stability and activity of these delicate biological molecules during transportation and storage across diverse and often challenging regional climates necessitates additional investment in cold chain logistics and specialized stabilizing agents. These compounding financial constraints force many local food and feed manufacturers to rely on cheaper traditional chemical hydrolysis methods or lower-quality imported enzyme blends. Thus, the high cost of production and distribution severely restricts the widespread adoption of premium protein hydrolysis enzymes among cost-sensitive regional industries.

Complex Regulatory Frameworks and Strict Labeling Mandates Delay Product Commercialization

The intricate and often fragmented regulatory landscape governing food additives and biocatalysts is a formidable barrier to the expansion of the Latin American protein hydrolysis enzyme market. This hampers the rapid commercialization of novel protein hydrolysis enzymes in the region. Each country maintains distinct approval pathways requiring extensive toxicological studies, safety assessments, and efficacy trials before a new enzyme can be legally incorporated into food or feed products. National sanitary registration boards across Latin America enforce distinct compliance timelines for novel food additives, creating complex pathways for foreign ingredient commercialization. These rigorous regulatory hurdles disproportionately affect innovative biotechnology companies that lack the extensive legal and financial resources to navigate multiple national approval systems simultaneously. The uncertainty surrounding regulatory outcomes and the high costs associated with compliance discourage rapid product innovation and limit the availability ofcutting-edgee hydrolytic solutions. This fragmented regulatory environment ultimately stifles the seamless introduction of advanced protein modification technologies across the diverse Latin American landscape.

MARKET OPPORTUNITIES

Conversion of Abundant Agro-Industrial Waste into High-Value Peptides and Amino Acids

The massive generation of agricultural and food processing byproducts offers a highly lucrative opportunity for the application of these enzymes in waste valorization, which is likely to drive the growth of the Latin American protein hydrolysis enzyme market. The region generates millions of tons of protein-rich organic waste annually from dairy processing, meat slaughterhouses,s and fisheries, es which currently poses significant environmental disposal challenges. According to the Food and Agriculture Organization of the United Nations,ons approximately 30 percent of all food produced globally is lost or wasted, sted with a substantial portion of this waste containing valuable recoverable proteins. These enzymatically derived hydrolysates can be repurposed as premium ingredients for animal feed, sports nutrition,rition and functional foods, transforming a costly disposal problem into a profitable revenue stream. By investing in enzymatic biorefineries, regional manufacturers can significantly reduce their environmental footprint while capitalizing on the growing global demand for sustainable and circular economy solutions. This immense potential for waste upcycling guarantees a robust expansion avenue for protein hydrolysis enzymes across the regional agro-industrial sector.

Development of Reusable Biocatalyst Systems to Enhance Industrial Process Efficiency

The rapid advancement of immobilized enzyme technologies creates a pathway to overcome cost barriers and significantly enhance the economic viability of protein hydrolysis processes in the region, which is expected to fuel the expansion of the Latin America protein hydrolysis enzyme market. Immobilization involves attaching enzymes to solid supports, allowing them to be easily recovered and reused across multiple continuous production cycles without losing their catalytic activity. As per the Brazilian Agricultural Research Corporation, recent technological breakthroughs in nanomaterial supports have dramatically increased the thermal and operational stability of proteases,s making them highly suitable for the rigorous conditions of industrial food and feed processing. This reusability not only makes advanced enzymatic hydrolysis economically competitive with traditional chemical methods but also aligns perfectly with the regional push toward greener and more sustainable manufacturing practices. By adopting these cutting-edge immobilization techniques, Latin American processors can achieve superior operational efficiencies and higher profit margins. This technological evolution opens the door for widespread industrial adoption of premium protein hydrolysis enzymes across cost-sensitive manufacturing sectors.

MARKET CHALLENGES

Maintaining Catalytic Stability Amidst Extreme Temperatures and pH Fluctuations

The inherent susceptibility of these delicate biological catalysts to denaturation under harsh industrial processing conditions is a persistent and formidable challenge in the Latin American protein hydrolysis enzyme market. Enzymes are highly sensitive to extreme temperatures,s fluctuating pH levels, ls and the presence of heavy metal ions, which can rapidly degrade their structural integrity and completely halt their catalytic activity. The natural variability of raw protein substrates further complicates the hydrolysis process, as inconsistent substrate quality can lead to unpredictable enzyme performance and incomplete protein cleavage. Overcoming this biological fragility requires continuous and expensive research into protein engineering and directed evolution to createhyper-stablee enzyme variants. Biocatalysts still suffer from unpredictable performance in large-scale applications. Until these stability issues are fully resolved, this remains a significant operational hurdle for regional manufacturers.

Economic Dominance of Acid and Alkali Hydrolysis Methods in Cost-Sensitive Markets

The intense economic competition from traditional chemical hydrolysis methods is also a major obstacle to the widespread adoption of biological protein hydrolysis enzymes across price-sensitive industries in the region, which negatively impacts the expansion of the Latin American market. Chemical hydrolysis utilizing strong acids or alkalis is a well-established and highly inexpensive process for breaking down proteins into amino acids for use in low-grade animal feed and industrial applications. Many local feed manufacturers and low-margin food processors prioritize short-term financial savings over the superior nutritional profile and safety benefits provided by enzymatic hydrolysis. This entrenched reliance on cheap chemical alternatives creates a massive pricing barrier for biological enzymes, forcing manufacturers to continuously justify the premium costs associated with biocatalysts. Overcoming this deeply ingrained economic preference requires extensive education and long-term cost-benefit analyses to demonstrate the true value of enzymatic processing.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Source Insights

In 2025, the microorganisms segment held the majority share of the Latin America protein hydrolysis enzyme market because of its unparalleled ability to produce high volumes of proteases through rapid fermentation processes. Unlike animal or plant sources, which are limited by seasonal harvests and slow biological growth cycles,s microbial strains such as bacteria and fungi can be cultivated in controlled bioreactors year-round with consistent output. The United Nations Industrial Development Organization (UNIDO) confirms that adopting continuous modern biotechnology and fermentation pathways improves raw material processing efficiency across developing economies. As per the Brazilian Agricultural Research Corporation,n the use of genetically optimized microbial strains allows manufacturers to tailor enzyme specificity for various industrial applications, ns ensuring maximum efficiency in protein breakdown. This scalability enables suppliers to meet the massive demand from the regional food and detergent industries without facing supply bottlenecks. The ability to continuously produce enzymes at an industrial scale ensures a stable and reliable supply chain, ain which is critical for large-scale manufacturing operations across the continent. This operational superiority cements microorganisms as the dominant source for protein hydrolysis enzymes in the region.

A further key factor driving the dominance of microbial sources is their significant cost advantage and lower environmental impact compared to animal- and plant-based alternatives. Producing enzymes from microorganisms requires significantly less land, water,r and energy than cultivating crops or raising livestock for enzyme extraction. Furthermore, microbial production generates fewer waste byproducts and avoids the ethical concerns associated with animal sourcing,g making it more acceptable to environmentally conscious consumers and regulatory bodies. The combination of lower production costs and sustainability benefits makes microbial enzymes the preferred choice for mass market applications such as detergents and animal feed. This economic and ecological efficiency guarantees the continued leadership of the microbial segment in the Latin American market.

The plant-based sources segment is expected to exhibit a noteworthy CAGR of 8.2% from 2026 to 2034, due to the surging consumer demand for natural, non-genetically modified,d and clean-label ingredients. Modern consumers in Latin America are increasingly scrutinizing product labels and rejecting synthetic or microbial-derived additives in favor of recognizable botanical sources such as papain from papaya and bromelain from pineapple. These botanical enzymes are perceived as safer and more holistic alternatives to microbial proteases, which are often viewed as industrial chemicals by the general public. The premium positioning of plant-based enzymes allows manufacturers to command higher prices and target the affluent urban demographic. This powerful consumer preference for natural wellness solutions ensures that the plant source segment will continue to expand at the fastest pace.

A different factor accelerating the plant segment is the abundant availability of indigenous tropical flora in Latin America that are naturally rich in potent proteolytic enzymes. Countries like Mexico, Brazil,l and Costa Rica are major global producers of papaya, ya pineapple, and figs,s which contain high concentrations of papain, bromelain,n and ficin, respectively. As per the Mexican Ministry of Agriculture and Rural Development,t local initiatives to valorize agricultural waste have led to the development of efficient extraction technologies that recover enzymes from fruit peels and cores that would otherwise be discarded. This utilization of agricultural byproducts not only reduces waste but also lowers the cost of raw materials for enzyme producers. The geographic advantage of having these enzyme-rich crops grown locally eliminates the need for expensive imports and supports rural economies. This unique combination of natural resource abundance and sustainable extraction practices positions Latin America as a global hub for plant-based enzyme production, driving rapid market growth.

By Application Insights

The food segment led the Latin America protein hydrolysis enzyme market and captured a significant share in 2025. This leading position of the segment was attributed to the massive scale of meat processing and the critical need for enzymatic tenderization to improve product quality and yield. Latin America is a global powerhouse in beef and poultry production, requiring extensive use of proteolytic enzymes to break down tough connective tissues and enhance meat texture. The Brazilian Animal Protein Association (ABPA) shows that the nation slaughters over 6 billion chickens annually, sustaining its market position as a premier global poultry exporter. These enzymes also accelerate the aging process of me, reducing the time and energy required for traditional aging methods. The relentless drive to optimize production efficiency and meet international export standards for meat quality ensures that the food industry remains the largest consumer of protein hydrolysis enzymes in the region. This structural dependence on enzymatic processing for meat value addition guarantees the segment's continued dominance.

Furthermore, an additional point keeping this segment on top is the growing demand for hydrolyzed protein ingredients in the dairy and bakery sectors to enhance nutritional value and functional properties. Protein hydrolysates are extensively used in infant formulas, sports nutrition products, and specialized medical foods to improve digestibility and reduce allergenicity. These functional benefits are crucial for meeting the evolving preferences of health-conscious consumers who prioritize nutritional density and convenience. The versatility of protein hydrolysis enzymes in creating diverse food formulations from hypoallergenic formulas to improved baked goods ensures their widespread adoption across the entire food manufacturing spectrum. This broad applicability within the food sector solidifies its position as the primary application area for these biocatalysts.

The pharmaceuticals segment is predicted to witness the highest CAGR of 9.5% during the forecast period owing to the rising prevalence of chronic diseases and digestive disorders that require enzymatic therapeutic interventions. Protein hydrolysis enzymes are increasingly used in treatments for exocrine pancreatic insufficiency, celiac disease, and other gastrointestinal conditions where natural protein digestion is compromised. As per the Pan American Health Organization,n the regional healthcare systems are expanding access to specialized medical nutrition and enzyme replacement therapies to manage these chronic conditions effectively. Proteolytic enzymes are also being investigated for their anti-inflammatory and fibrinolytic properties in treating cardiovascular diseases and wound healing. The growing clinical evidence supporting the therapeutic efficacy of these enzymes is driving their inclusion in standard treatment protocols. This increasing medical recognition and the expanding patient base ensure that the pharmaceutical application of protein hydrolysis enzymes will experience rapid and sustained growth.

Furthermore, a key driver maintaining this segment's lead is the advancements in drug delivery systems and the booming research into bioactive peptides for novel therapeutic applications. Protein hydrolysis enzymes are essential for producing specific bioactive peptides that exhibit antihypertensive, antimicrobial,l and immunomodulatory effects, which are being developed into new pharmaceutical drugs. The ability of proteases to precisely cleave proteins into specific active sequences makes them indispensable tools in modern drug discovery and development. This scientific innovation is attracting significant funding from both public and private sectors, accelerating the commercialization ofenzyme-basedd pharmaceutical products. The convergence of enzymatic technology and advanced pharmacology guarantees that the pharmaceutical segment will remain the fastest-growing application area.

COUNTRY LEVEL ANALYSIS

Brazil Protein Hydrolysis Enzyme Market Analysis

Brazil dominated the Latin American protein hydrolysis enzyme market and occupied a 34.8% share in 2025. This dominance of the segment was driven by its massive agricultural output and robust industrial base. This country's market is known for a highly developed food processing industry and major investments from international enzyme companies. According to the Brazilian Institute of Geography and Statistics (IBGE), primary agriculture and livestock productionalone accountss for approximately 6% of national GDP, while the broader integrated agrifood sector pushes total economic contribution significantly higher. Also, the Brazilian Agricultural Research Corporation (Embrapa) confirms Brazil's position as a dominant global supplier of soybeans and animal proteins, driving advanced biotechnology utilization across regional supply chains. The government's support for biotechnology innovation through agencies like Embrapa has fostered a conducive environment for local enzyme production and research. Furthermore, the rising health consciousness among the urban population is driving the demand for dietary supplements and functional foods containing hydrolyzed proteins. The combination of agricultural strength, industrial capacity, a nd technological advancement ensures that Brazil remains the undisputed leader in the Latin American protein hydrolysis enzyme market.

Mexico Protein Hydrolysis Enzyme Market Analysis

Mexico was the next prominent country in the regional market and captured a 25.1% share in 2025. This growth of the Mexican market was fuelled by its strategic trade links and diverse food industry. The market status in this country is heavily influenced by its proximity to the United States and the extensive integration of its manufacturing sector with North American supply chains. According to the Mexican Ministry of Economy and INEGI, food and beverage processing remains a cornerstone of the country's secondary activities, representing about 4% of Mexico's total gross domestic product. Also, the National Institute of Statistics and Geography (INEGI) highlights that processed meats, dairy products, and baked goods lead growth within Mexico's domestic food manufacturing sector. The presence of major global enzyme suppliers in the region facilitates easy access to high-quality products for local manufacturers. Furthermore, the growing trend of health and wellness among Mexican consumers is boosting the demand for sports nutrition and medical foods. The strong industrial foundation and favorable trade agreements ensure that Mexico remains a critical and rapidly growing market for protein hydrolysis enzymes.

Argentina Protein Hydrolysis Enzyme Market Analysis

Argentina occupies a significant third position in the Latin American protein hydrolysis enzyme market due to its world-class beef and dairy industries. The country’s market position reveals its high-quality agricultural products and a strong tradition of food processing excellence. According to the Argentine Institute of Statistics and Censuses, the country is one of the top exporters of beef and dairy products globally,y creating a consistent demand for enzymatic tenderizers and protein modifiers. As per the Argentine Chamber of Food Industries, the local manufacturing sector is increasingly adopting advanced biotechnological solutions to improve product consistency and meet international export standards. The economic challenges in the country have prompted manufacturers to seek cost-effective and efficient production methods, further driving the adoption of enzymes. Additionally, the growing awareness of digestive health issues is stimulating the market for enzymatic supplements and functional foods. The reliance on high-value agricultural exports and the need for operational efficiency ensure that Argentina remains a vital player in the regional enzyme market.

Chile Protein Hydrolysis Enzyme Market Analysis

Chile is moving ahead steadfastly in the regional market owing to its advanced regulatory framework and strong focus on innovation. The nation's market boasts highly advanced food and pharmaceutical sectors, driven by strict compliance with global quality standards. Moreover, the Chilean Office of Agricultural Studies and Policies (Odepa) confirms that Chile ships more than 2.6 million tons of fresh fruit annually to global markets. As per the Chilean Economic Development Agency,y the government actively promotes biotechnology and innovation through grants and partnerships with research institutions. The high disposable income and health-conscious population drive the demand for premium nutritional products and enzymatic therapies. Furthermore, thecountry'sy stable economic environment attracts foreign investment in the biotechnology sector. The combination of regulatory rigor, innovative culture, and high-quality exports ensures that Chile remains a key and influential market for protein hydrolysis enzymes in Latin America.

COMPETITIVE LANDSCAPE

The competition in the Latin American Protein Hydrolysis Enzyme Market is characterized by intense rivalry among multinational biochemical giants and emerging regional suppliers. Established players leverage their extensive research capabilities and broad product portfolios to dominate high-value segments such as pharmaceuticals and specialized food ingredients. Local competitors often compete on price by offering generic enzyme blends, making them attractive to cost-sensitive small and medium enterprises. Product differentiation is achieved through enhanced stability, specificity,y, and ease of application, which are critical factors in diverse industrial environments. Regulatory compliance serves as a significant barrier to entry, prompting companies to invest heavily in obtaining necessary approvals and certifications. Strategic alliances with local distributors and industry associations are essential for ensuring broad market coverage and timely product delivery. Intellectual property protection around proprietary enzyme strains provides a competitive edge for innovators. Customer loyalty is driven by consistent product quality,y reliable supply chains, and responsive technical support services. The market sees continuous efforts to educate users on the benefits of enzymatic processing over traditional chemical methods. Collaborative ecosystems involving suppliers, rregulators,and growers accelerate the adoption of sustainable and efficient bioprocessing solutions.

KEY MARKET PLAYERS

Some of the companies that are playing a dominant role in the Latin America Protein Hydrolysis Enzymes Market include

• AB Enzymes GmbH
• Dyadic International, Inc.
• Solvay Enzymes
• Royal DSM (DSM-Firmenich)
• Novozymes A/S (Novonesis)
• Specialty Enzymes & Biotechnologies Co.

TOP LEADING PLAYERS IN THE MARKET

• Novozymes A/S operates as a global leader in industrial enzymes with a significant andwell-establishedd presence across Latin America. The company provides a comprehensive portfolio of proteases tailored for food processing, animal feed, and detergent applications. Recent actions include expanding its technical service centers in Brazil and Mexico to provide localized support and customized solutions for regional manufacturers. Novozymes actively collaborates with local agricultural cooperatives to promote sustainable enzyme usage in waste valorization projects. Their investment in research and development focuses on creating heat-stable and pH-tolerant enzymes suitable for diverse industrial conditions. Novozymes continuously prioritizes sustainability and innovation. By doing so, the company strengthens its reputation as a trusted partner for improving efficiency and reducing environmental impact in the Latin American bioprocessing sector.
• DuPont de Nemours Inc is a major player in the Latin American protein hydrolysis enzyme market, et leveraging its extensive expertise in nutrition and biosciences. The company offers high-performance enzymatic solutions that enhance protein digestibility and functional properties in food and feed products. Recent actions involve launching new specialized protease formulations designed specifically for the regional meat and dairy industries to improve yield and texture. DuPont partners with local universities and research institutions to advance biotechnological innovations and address specific regional challenges. They also focus on digital tools to help customers optimize enzyme dosage and application processes. DuPont continues to reinforce its position as a leading provider of advanced biological solutions through strategic acquisitions and organic growth. In turn, this strategic approach drives productivity and sustainability across Latin American industries.
• BASF SE serves as a prominent supplier of industrial enzymes and chemical solutions with a growing footprint in the Latin American market. The company utilizes its strong chemical manufacturing infrastructure to produce and distribute high-quality protein hydrolysis enzymes for various applications. Recent actions include strengthening its distribution network in Argentina and Chile to ensure reliable supply and faster delivery to local clients. BASF invests heavily in developing cost-effective enzymatic blends that compete with traditional chemical methods in cost-sensitive markets. They also engage in educational initiatives to raise awareness about the benefits of enzymatic processing among small and medium enterprises. BASF enhances its competitive edge by combining chemical expertise with biological innovation. This integration supports the modernization of industrial processes across Latin America.

TOP STRATEGIES USED BY KEY MARKET PARTICIPANTS

Key players in the Latin America Protein Hydrolysis Enzyme Market primarily focus on strategic partnerships with local agricultural and food processing companies to develop customized enzymatic solutions. Companies invest heavily in research and development to create robust enzymes that withstand harsh industrial conditions and offer superior performance. Market participants prioritize regulatory compliance by navigating complex approval processes in different countries to ensure seamless product availability. Expansion of local technical support teams enables better customer engagement and application optimization. Sustainability initiatives such as waste valorization and green manufacturing are central to brand positioning and corporate responsibility. Digitalization through data analytics helps customers monitor enzyme performance and improve operational efficiency. Pricing strategies balance premium positioning for specialized products with competitive rates for mass market applications. These multifaceted approaches drive sustainable growth and strengthen competitive positions in the evolving regional market.

MARKET SEGMENTATION

This research report on the Latin America Protein Hydrolysis Enzymes Market has been segmented and sub-segmented into the following categories.

By Source

• Microorganisms
• Animals
• Plants

By Application

• Detergent Industry
• Pharmaceuticals
• Food Industry
• Others

By Country

• Mexico
• Brazil
• Argentina
• Chile
• Rest of Latin America